Topic
Mash
3 stories about Mash that passed the news check, newest first.
Research ·
TLR5 drives metabolic dysfunction-associated steatohepatitis through lipid- and flagellin-induced hepatocyte injury signaling
A study in Science Advances reports that TLR5 drives metabolic dysfunction-associated steatohepatitis (MASH).
science.org
Research ·
Selective mTOR inhibition via FLCN drives TFE3-dependent VLDL-TG secretion and protects from MAFLD/MASH
A Nature Communications study reports a pathway in which selective, non-canonical mTOR signaling via FLCN regulates VLDL assembly and secretion.
nature.com
Research ·
Early Response to MASH Drug Linked to Resolution, Fibrosis Improvement
In patients treated with resmetirom (Rezdiffra), early responses in blood and imaging biomarkers were associated with resolution of MASH.
MedPageToday.com - medical news for physicians